Hengxu Mao
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments 10
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Botulinum Toxin and Related Neurological Disorders 2
-
- Parkinson's Disease Mechanisms and Treatments 10
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Botulinum Toxin and Related Neurological Disorders 2
-
- RNA regulation and disease 2
- Mitochondrial Function and Pathology 2
-
- Alzheimer's disease research and treatments 2
- Cited by
- Cancer ResearchNeurology
- Journals
- Cellular and Molecular Life Sciences (2 papers)Experimental Neurology (1 paper)International Journal of Biological Macromolecules (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Hengxu Mao
21 papers receiving 491 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 205
- Neurology 100
- Neurology 88
- Biological Psychiatry 13
- Cellular and Molecular Neuroscience 82
Countries citing papers authored by Hengxu Mao
This map shows the geographic impact of Hengxu Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengxu Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengxu Mao more than expected).
Fields of papers citing papers by Hengxu Mao
This network shows the impact of papers produced by Hengxu Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengxu Mao. The network helps show where Hengxu Mao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hengxu Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 13 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 28 | |
| 10 | 2021 | 58 | |
| 11 | 2021 | 12 | |
| 12 | 2020 | 15 | |
| 13 | 2019 | 76 | |
| 14 | 2018 | 78 | |
| 15 | 2018 | 13 | |
| 16 | 2018 | 121 | |
| 17 | 2017 | 3 | |
| 18 | 2011 | 4 | |
| 19 | [Experimental studies of icariin on anticancer mechanism]. | 2000 | 10 |
| 20 | [Influence of icariin on cell membrane of highly metastatic human lung tumor cell line]. | 1999 | 1 |
About Hengxu Mao
Hengxu Mao is a scholar working on Neurology, Cancer Research and Neurology, having authored 22 papers that have together received 499 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (10 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), RNA regulation and disease (2 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), Alzheimer's disease research and treatments (2 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Cancer Research (205 citations), Neurology (100 citations) and Neurology (88 citations). Hengxu Mao has collaborated with scholars based in China and United States. Frequent co-authors include Shizhong Zhang, Yongyi Ye, Longping Yao, Xiaozheng He, Fengfei Lu, Guohui Lu, Baoyan Wang, Xiang Sun, Chen Qian and Yizhou Zhang. Their work appears in journals such as Cellular and Molecular Life Sciences, Experimental Neurology, International Journal of Biological Macromolecules, Cell Death and Disease and Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.